Pharma Aids Past Earnings Performance
Past criteria checks 2/6
Pharma Aids's earnings have been declining at an average annual rate of -12.6%, while the Packaging industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 11.9% per year. Pharma Aids's return on equity is 18.7%, and it has net margins of 15.6%.
Key information
-12.6%
Earnings growth rate
-12.6%
EPS growth rate
| Packaging Industry Growth | 2.6% |
| Revenue growth rate | 11.9% |
| Return on equity | 18.7% |
| Net Margin | 15.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pharma Aids makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 431 | 67 | 44 | 0 |
| 30 Jun 24 | 421 | 61 | 44 | 0 |
| 31 Mar 24 | 409 | 51 | 44 | 0 |
| 31 Dec 23 | 376 | 24 | 42 | 0 |
| 30 Sep 23 | 329 | -1 | 38 | 0 |
| 30 Jun 23 | 308 | -6 | 37 | 0 |
| 31 Mar 23 | 302 | -13 | 46 | 0 |
| 31 Dec 22 | 303 | 5 | 46 | 0 |
| 30 Sep 22 | 310 | 25 | 46 | 0 |
| 30 Jun 22 | 323 | 35 | 47 | 0 |
| 31 Mar 22 | 325 | 60 | 40 | 0 |
| 31 Dec 21 | 315 | 58 | 39 | 0 |
| 30 Sep 21 | 301 | 54 | 39 | 0 |
| 30 Jun 21 | 280 | 50 | 38 | 0 |
| 31 Mar 21 | 272 | 46 | 37 | 0 |
| 31 Dec 20 | 255 | 47 | 35 | 0 |
| 30 Sep 20 | 262 | 51 | 34 | 0 |
| 30 Jun 20 | 270 | 52 | 34 | 0 |
| 30 Jun 19 | 249 | 48 | 30 | 0 |
| 30 Jun 18 | 235 | 47 | 26 | 0 |
| 31 Mar 18 | 227 | 46 | 24 | 0 |
| 31 Dec 17 | 212 | 39 | 24 | 0 |
| 30 Sep 17 | 193 | 35 | 22 | 0 |
| 30 Jun 17 | 180 | 30 | 21 | 0 |
| 31 Mar 17 | 176 | 28 | 20 | 0 |
| 31 Dec 16 | 166 | 26 | 19 | 0 |
| 30 Sep 16 | 161 | 25 | 18 | 0 |
| 30 Jun 16 | 152 | 23 | 17 | 0 |
| 31 Mar 16 | 139 | 23 | 17 | 0 |
| 31 Dec 15 | 137 | 22 | 16 | 0 |
| 30 Sep 15 | 138 | 23 | 16 | 0 |
| 30 Jun 15 | 147 | 25 | 15 | 0 |
| 31 Mar 15 | 154 | 27 | 16 | 0 |
| 31 Dec 14 | 150 | 27 | 15 | 0 |
| 30 Sep 14 | 137 | 22 | 14 | 0 |
| 30 Jun 14 | 126 | 17 | 14 | 0 |
| 31 Mar 14 | 112 | 12 | 13 | 0 |
| 31 Dec 13 | 100 | 6 | 12 | 0 |
Quality Earnings: PHARMAID has high quality earnings.
Growing Profit Margin: PHARMAID became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PHARMAID's earnings have declined by 12.6% per year over the past 5 years.
Accelerating Growth: PHARMAID has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PHARMAID has become profitable in the last year, making it difficult to compare its past year earnings growth to the Packaging industry (14.9%).
Return on Equity
High ROE: PHARMAID's Return on Equity (18.7%) is considered low.